Profound Medical (PROF)
(Delayed Data from NSDQ)
$7.80 USD
-0.04 (-0.51%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.87 +0.07 (0.90%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Profound Medical falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.57 | -28.67 | -30.70 | -21.62 | -15.22 |
Depreciation/Amortization & Depletion | 1.15 | 1.60 | 1.88 | 1.54 | 1.52 |
Net Change from Assets/Liabilities | 0.37 | -5.63 | -1.05 | -5.83 | -3.68 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.75 | 6.89 | 7.51 | 5.34 | 2.28 |
Net Cash From Operating Activities | -22.30 | -25.80 | -22.36 | -20.57 | -15.09 |
Property & Equipment | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -0.56 | -0.35 | -0.19 |
Net Cash from Investing Activities | 0.00 | 0.00 | -0.59 | -0.35 | -0.19 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.67 | 0.26 | 6.43 | 103.68 | 8.67 |
Issuance (Repayment) of Debt | -0.91 | 7.23 | 0.00 | -9.32 | -1.00 |
Increase (Decrease) Short-Term Debt | -0.29 | -0.31 | -0.39 | -0.29 | -0.24 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.15 | -0.10 | -6.64 | -0.78 |
Net Cash from Financing Activities | 1.46 | 7.03 | 5.95 | 87.43 | 6.64 |
Effect of Exchange Rate Changes | 0.53 | -1.87 | 0.24 | 2.60 | 0.00 |
Net Change In Cash & Equivalents | -20.30 | -20.64 | -16.76 | 69.11 | -8.64 |
Cash at Beginning of Period | 46.52 | 67.15 | 83.91 | 14.80 | 23.13 |
Cash at End of Period | 26.21 | 46.52 | 67.15 | 83.91 | 14.49 |
Diluted Net EPS | -1.35 | -1.38 | -1.50 | -1.25 | -1.37 |
Fiscal Year End for Profound Medical falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.12 | -6.20 | -28.57 | -19.66 | -14.10 |
Depreciation/Amortization & Depletion | 0.59 | 0.31 | 1.15 | 0.85 | 0.56 |
Net Change from Assets/Liabilities | -0.65 | 0.03 | 0.37 | 0.17 | 0.08 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.72 | 0.77 | 4.75 | 3.37 | 2.51 |
Net Cash From Operating Activities | -11.45 | -5.10 | -22.30 | -15.28 | -10.94 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 22.94 | 22.94 | 2.67 | 2.66 | 2.66 |
Issuance (Repayment) of Debt | -1.23 | -0.62 | -0.91 | -0.49 | -0.37 |
Increase (Decrease) Short-Term Debt | -0.15 | -0.07 | -0.29 | -0.22 | -0.15 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.86 | -1.86 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 19.71 | 20.38 | 1.46 | 1.96 | 2.14 |
Effect of Exchange Rate Changes | -0.39 | -0.32 | 0.53 | 0.43 | 1.56 |
Net Change In Cash & Equivalents | 7.87 | 14.97 | -20.30 | -12.89 | -7.24 |
Cash at Beginning of Period | 26.21 | 26.21 | 46.52 | 46.52 | 46.52 |
Cash at End of Period | 34.08 | 41.18 | 26.21 | 33.63 | 39.28 |
Diluted Net EPS | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |